Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription The Independent UK · Aug 15, 2025
Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss. International Business Times UK · Aug 15, 2025
Scientists Discover Ozempic’s Healthier Rival With No Nausea And No Side Effects "Like starting the race halfway through.” Bored Panda · Aug 14, 2025
‘Life-threatening’: Thousands of bogus online pharmacies selling fake Ozempic jabs Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent medications could be fatal The Independent UK · Aug 14, 2025
Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands The US president had put pressure on the pharmaceutical industry to make drugs cheaper for Americans The Guardian - UK · Aug 14, 2025
Ozempic didn’t work for me. I was furious – and ashamed Everyone taking the ‘skinny shot’ was losing weight, but my scales didn’t change. My inner dialogue became toxic The Guardian - US · Aug 14, 2025
Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro by up to 170% The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS). Euronews · Aug 14, 2025
'Ferrand-Prévot’s weight loss for the Tour puts pressure on all of us,' says Marlen Reusser Doctor and competitor Marlen Reusser says Ferrand-Prévot’s weight loss sets a worrying standard for the peloton Cycling Weekly · Aug 13, 2025
Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss. Benzinga · Aug 13, 2025
The targeted programme found to improve IVF outcomes Women who took part in a weight loss programme had a 21 per cent higher chance of becoming pregnant – whether naturally or through IVF The Independent UK · Aug 13, 2025
Altimmune Q2 FY2025 Earnings Call Transcript Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell. Benzinga · Aug 12, 2025
Weight loss support before IVF could boost pregnancy chances – and reduce the need for treatment Around one in five women of childbearing age are living with [obesity], defined by the World Health Organization as having a body mass index (BMI) over 30 kg/m². Compared with women in the healthy BMI range (18.5–24.9 kg/m²), those living with obesity are three times more likely to experience fertility… The Conversation · Aug 12, 2025
AAP · Aug 11, 2025 Patient's heartbreaking final words before death A woman uttered five striking words to her family from her hospital bed before she died of complications arising from her pursuit of a healthier life.
MarketBeat · Aug 9, 2025 Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.
MarketBeat · Aug 8, 2025 Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Weight loss drug goliath Eli Lilly just tanked despite posting impressive Q2 results. See what drove the decline and whether the market reaction is overdone.
Euronews · Aug 8, 2025 Portugal tightens rules on weight loss drug prescriptions to prevent misuse Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.
The Independent UK · Aug 8, 2025 Tammy Slaton defends decision to drink soda ‘in moderation’ amid weight loss journey IN FULL
The Guardian - UK · Aug 7, 2025 Daily pill helps patients lose 12% of body weight in early trial Results of study suggest orforglipron could be a simpler, cheaper alternative to injections
The Conversation · Aug 7, 2025 Weight loss jabs and cancer risk: here’s what you need to know about the research so far So many people in western countries are turning to weight loss drugs such as Wegovy/Ozempic and Mounjaro that concerns have started to emerge about maintaining ready supplies. But with popularity comes scrutiny, and rising demand isn’t the only potential problem with weight loss jabs.
International Business Times UK · Aug 7, 2025 'Ozempic Penis'? Male Users Claim Genital Growth After Weight Loss Jab Goes Viral Men using Ozempic report genital growth after weight loss. Doctors say it's fat loss, not drug-related changes, sparking viral debate online.
Barchart · Aug 7, 2025 This Blue-Chip Stock Is Cooking Up a Major Growth Catalyst Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.
Euronews · Aug 7, 2025 Eli Lilly will seek approval for experimental weight loss pill after promising study Study participants lost an average of 12.4 per cent of their body weight over 72 weeks.